Related stories
JPMorgan cut Polymarket as banking client over regulatory concerns
Jasper Therapeutics beats Q2 expectations but shares fall after results
Accendra Health drops equity issuance plan as CEO succession process advances
Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum
'I used food banks while my ex owed thousands in child maintenance'
LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances